Clarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Gross Profit

Gross Profit analysis for CRXT.

Quarterly Gross Profit

$2.89M

↑ 29.89% YoY

As of Jun 30, 2022

Annual Gross Profit (TTM)

$15.25M

↑ 263.76% YoY

Trailing 12 months ending Jun 30, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin